[1] Dobazewski M, Chen W, Frangogiannis NG. Transfoming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol,2011,51:600-606.
[2] Hayashida T. Intergrins modulate cellular fibrogenesis at multiple levels; Regulation of TGF-β signaling.Endocr Metab Immune Disord Drug Targets, 2010, 10:302-319.
[3] Bataller R, Brenner DA. Liver fibrosis. J Clin Invest, 2005, 115:209-218.
[4] Blank U, Karlsson S. The role of Smad signaling in hematopoiesis and translational hematology. Leukemia, 2011, 25:1379-1388.
[5] Wang W, Koka V, Lan HY. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton), 2005, 10:48-56.
[6] Santibañez JF, Quintanilla M, Bernabeu C.TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci (Lond), 2011,121:233-251.
[7] Bowen T, Jenkins RH, Fraser DJ. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. J Pathol, 2013, 229:274-285.
[8] Li ZJ, Ou-Yang PH, Han XP. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells. Cell Signal, 2014, 26:141-148.
[9] Hu J, Chen C, Liu Q, et al. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis. Clin Sci (Lond), 2015,129:305-317.
[10] Mungunsukh O, Day RM. Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism. Mol Biol Cell, 2013, 24:2088-2097.
[11] Zheng J, Lin Z, Dong P, et al. Activation of hepatic stellate cells is suppressed by microRNA-150. Int J Mol Med, 2013, 32:17-24.
[12] Bian EB, Huang C, Wang H,et al. Repression of Smad7mediated by DNMT1 determines hepatic stellate cell activation and liver fibrosis in rats. Toxicol Lett, 2014,224:175-185.
[13] Ding N, Yu RT, Subramaniam N, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell, 2013, 153:601-613.
[14] Rocher C, Singla R, Singal PK, et al. Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages. Can J Pharmacol, 2012,90: 947-951.
[15] Xu F, Liu C, Zhou D, et al. TGF-β/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem, 2016, 64: 157-167.
[16] Sancho P, Mainez J, Crosas-Molist E, et al. NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. PLoS One, 2012, 7:1-14.
[17] Jiang JX, Chen X, Serizawa N, et al. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med, 2012, 53:289-296.
[18] Park SA, Kim MJ, Park SY, et al. EW-7197 inhibits hepatic renal and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling. Cell Mol Life Sci, 2015, 72:2023-2039.
[19] Wang B, Li W, Chen Y, et al. Coexpression of Smad7 and UPA attenuates carbon tetrarchloride-induced rat liver fibrosis. Med Sci Monit, 2012, 18:BR394-401.
[20] Xiao X, Huang C, Zhao C, et al. Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition. Arch Biochem Biophys, 2015, 566:49-57.
[21] Zhu D, He X, Duan Y, et al. Expression of microRNA-454 in TGF-β1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum. Parasit Vectors, 2014, 7:148.
[22] Tu X, Zheng X, Li H, et al.MicroRNA-30 protects against carbon tetrachloride-induced liver fibrosis by attenuating transforming growth factor beta signaling in hepatic stellate cells. Toxicol Sci, 2015,146:157-169.
[23] Yu F, Guo Y, Chen B, et al. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest, 2015, 95:781-789.
[24] Sun X, He Y, Ma TT, et al. Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation. Mol Cell Biochem, 2014, 388:11-23.
[25] Zhang Z, Zha Y, Hu W, et al. The autoregulatory feedback loop of microRNA-21/ programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem, 2013, 288:37082-37093.
[26] Zhang Z, Gao Z, Hu W, et al. 330-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21expression. Br J Pharmacol, 2013,170:649-660.
[27] Huang W, Li L, Tian X, et al. Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway. Mol Med Rep, 2014, 11:2569-2577.
[28] Clichici S, Olteanu D, Nagy AL, et al. Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl4 -treated rats. J Med Food, 2015,18:290-298.
[29] Fan X, Zhang Q, Li S, et al. Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1. PLoS One, 2013, 8: e82190.
[30] Pardali E, ten Dijke P. Transforming growth factor-beta signaling and tumor angiogenesis. Front Biosci(Landmark Ed), 2009, 14:4848-4861. |
